Correlation Between Amgen and Avadel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Amgen and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Amgen and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Avadel Pharmaceuticals.
Diversification Opportunities for Amgen and Avadel Pharmaceuticals
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Amgen and Avadel is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Amgen i.e., Amgen and Avadel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Amgen and Avadel Pharmaceuticals
Given the investment horizon of 90 days Amgen Inc is expected to generate 0.39 times more return on investment than Avadel Pharmaceuticals. However, Amgen Inc is 2.56 times less risky than Avadel Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.09 per unit of risk. If you would invest 32,789 in Amgen Inc on September 2, 2024 and sell it today you would lose (4,502) from holding Amgen Inc or give up 13.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Amgen Inc vs. Avadel Pharmaceuticals PLC
Performance |
Timeline |
Amgen Inc |
Avadel Pharmaceuticals |
Amgen and Avadel Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amgen and Avadel Pharmaceuticals
The main advantage of trading using opposite Amgen and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.The idea behind Amgen Inc and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Avadel Pharmaceuticals vs. Neurocrine Biosciences | Avadel Pharmaceuticals vs. Ironwood Pharmaceuticals | Avadel Pharmaceuticals vs. Alkermes Plc | Avadel Pharmaceuticals vs. Intracellular Th |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |